Today

Agents

Chat

Arena

Discover

More

App

Inhibitor Therapeutics announces annual shareholder meeting - INTI News | Rallies

Inhibitor Therapeutics announces annual shareholder meeting

INTI•2026-09-08

Annual stockholders’ meeting set for Sept. 15, 2026

Inhibitor Therapeutics will hold its annual stockholders’ meeting virtually on Sept. 15, 2026.

Stockholders will vote on matters set out in the company’s 2026 definitive proxy statement.

Related News

DSS director and 10% owner Chan Heng Fai Ambrose sells USD 17,918 common shares

DSS•2026-09-08

nLIGHT CFO Joseph John Corso disposes of 7,715 common shares worth $321,274.31

LASR•2026-09-08

Constellation Brands to redeem USD 600 million senior notes due 2027 on Sept. 18

STZ

•

2026-09-08

Camden Property Trust guides 2026 core FFO per share at $6.68-$6.82

CPT•2026-09-08

Vivos Therapeutics amends 8-K to correct report date to Sept. 2, 2026

VVOS•2026-09-08